Camron D. Bryant

Camron D. Bryant

Auto-generated profile, based on publicly available information

Camron D. Bryant

Northeastern University

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Journal of Neurogenetics
Verified
Journal Article
Closed access
CBCamron D. Bryant
Camron D. Bryant
NZNanci N. Zhang
Nanci N. Zhang
GSGreta Sokoloff
Greta Sokoloff
MFMichael S. Fanselow
Michael S. Fanselow
HEHelena S. Ennes
Helena S. Ennes
JMJames A. McRoberts
James A. McRoberts
Separate breeding colonies of C57BL/6 (“B6”) mice maintained at the Jackson Laboratories (“J”) and NIH (“N”) have led to the emergence of two distinct substrains of C57BL/6 mice: C57BL/6J and C57BL/6N. Molecular genetic studies indicate simple sequence-length polymorphisms, single-nucleotide polymorphisms, and copy-number variants among B6 substrains that may contribute to phenotypic differences. We examined differences in motor coordination, pain sensitivity, and conditional fear in the C57BL/6J strain and three N strains: C57BL/6NCrl (Charles River), C57BL/6NTac (Taconic), and C57BL/6NHsd (Harlan Sprague Dawley). Male C57BL/6J mice demonstrated enhanced motor coordination, as measured by the rotarod assay, markedly enhanced pain sensitivity in two assays of acute thermal nociception (e.g., tail withdrawal and hot plate), and a reduced level of conditional fear. The tail withdrawal result was confirmed in a separate laboratory. We also provide a table reviewing previously reported behavioral differences among various B6 substrains and discuss the significance of environmental differences due to obtaining mice form different vendors. These data may be seen as a potential problem and as a potential opportunity. Great care must be taken when working with mice engineered by using B6 embryonic stem cell lines because control groups, backcrosses, and intercrosses could inadvertently introduce behaviorally significant polymorphic alleles or environmental confounds. On the other hand, deliberate crosses between B6 substrains may provide an opportunity to map polymorphic loci that contribute to variability in a trait on largely homogenous backgrounds, which has the potential to improve mapping resolution and aid in the selection of candidate genes.

6 May 2022 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CBCynthia Bulik
Cynthia Bulik
Jonathan ColemanJonathan Coleman
Jonathan Coleman
JHJ. Andrew Hardaway
J. Andrew Hardaway
LBLauren Breithaupt
Lauren Breithaupt
HWHunna J. Watson
Hunna J. Watson
GBGerome Breen
Gerome Breen

29 December 2011 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBCamron D. Bryant
Camron D. Bryant

10 September 2003 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SEShoshana Eitan
Shoshana Eitan
CBCamron D. Bryant
Camron D. Bryant
NSNazli Saliminejad
Nazli Saliminejad
YYYu C. Yang
Yu C. Yang
EVElroy Vojdani
Elroy Vojdani
CEChristopher J. Evans
Christopher J. Evans
Opioid-receptor activation in cell lines results in phosphorylation of p42/44 mitogen-activated protein kinase (MAPK), which contributes to agonist-induced desensitization of adenylate cyclase signaling. In this study, morphine-induced MAPK modulation was examined in the mouse brain using antibodies against phosphorylated MAPK. Thirty minutes after systemic morphine, MAPK modulation was observed in brain areas associated with analgesia and reward. Activation of MAPK was increased in the anterior cingulate (Acc), somato-sensory and association cortices, and locus ceruleus (LC). In contrast, MAPK activation was decreased in the nucleus accumbens and central amygdala (CeA). Double-label confocal microscopy revealed that morphine-induced MAPK modulation occurred predominantly in cells not expressing μ-opioid receptors, with the exception of the LC. Furthermore, the NMDA receptor antagonist 3,3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonate blocked morphine-induced MAPK modulation in several cortical areas including the Acc. We then examined morphine-induced MAPK modulation during expression of either analgesic tolerance or locomotor sensitization, which were differentiated by two repeated morphine regimens. Analgesic tolerance was accompanied by tolerance to morphine-induced MAPK modulation in all of the brain areas examined except the CeA. Locomotor sensitization resulted in sensitization to morphine-induced MAPK activation in the posterior basolateral amygdala. Additionally, a pronounced instatement of morphine-induced MAPK activation was observed in CA3 hippocampal processes. This instatement was observed during expression of tolerance; however, it was not significant during sensitization. In summary, these results provide distinct, region-specific mechanisms for morphine-induced MAPK modulation in the mouse brain and give insight into the brain circuitry involved in acute and adaptive opioid behaviors.

1 May 2017 in Biological Psychiatry
Verified
Journal Article
Closed access
SKStacey L. Kirkpatrick
Stacey L. Kirkpatrick
LGLisa R. Goldberg
Lisa R. Goldberg
NYNeema Yazdani
Neema Yazdani
RBR. Keith Babbs
R. Keith Babbs
JWJiayi Wu
Jiayi Wu
CBCamron D. Bryant
Camron D. Bryant

1 January 2008 in Hormones and Behavior
Verified
Journal Article
Closed access
LGLaura Gioiosa
Laura Gioiosa
XCXuqi Chen
Xuqi Chen
RWRebecca Watkins
Rebecca Watkins
NKNicole Klanfer
Nicole Klanfer
CBCamron D. Bryant
Camron D. Bryant
AAArthur P. Arnold
Arthur P. Arnold